IMPACT OF PRELIMINARY PREPARATION ON THE OUTCOMES OF ASSISTED REPRODUCTIVE TECHNOLOGY PROGRAMS IN GONADOTROPIN-RELEASING HORMONE ANTAGONIST PROTOCOLS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The review discusses current views on the impact of induced cycle programming on the outcomes of assisted reproductive technology programs. Ovarian stimulation protocols with gonadotropin-releasing hormone antagonists are commonly used in routine clinical practice, simple and easy-to-use for both the patient and the physician. It is precisely this makes us look for ways to enhance their efficiency.

Full Text

Restricted Access

About the authors

M. V MARTYNOVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: Martinova_m@bk.ru
Moscow

N. G MISHIYEVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: nondoc555@mail.ru
Moscow

L. V VINOGRADOVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: Kalugina-LV@yandex.ru
Moscow

A. N ABUBAKIROV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia

Email: nondoc555@yahoo.com
Moscow

References

  1. Кулаков В.И., Леонов Б.В., Кузьмичёв Л.Н. Лечение женского и мужского бесплодия. Вспомогательные репродуктивные технологии. М.: МИА; 2008. 592 с.
  2. Кулаков В.И. Репродуктивное здоровье: проблемы, достижения, перспективы. Проблемы репродукции. 1999; 2: 2—5.
  3. Кулаков В.И. Репродуктивное здоровье населения России. Гинекология. 2007; 9(1): 7—9.
  4. Назаренко Т.А. Синдром поликистозных яичников: современные подходы к диагностике и лечению бесплодия. М.: МЕДпресс-информ; 2005: 100—38.
  5. Леонов Б.В., Яворовская К.А., Осина Е.А. Применение гонадотропин-рилизинг гормона в программе ЭКО. В кн.: Прилепская В.Н., ред. Поликлиническая гинекология. М.; 2005: 242—52.
  6. Venetis C.A., Kolibianakis E.M., Papanikolaou E., Bontis J., Devroey P., Tarlatzis B.C. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum. Reprod. Update. 2007; 13(4): 343—55.
  7. Ubaldi F., Camus M., Smitz J., Bennink H.C., Van Steirteghem A., Devroey P. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil. Steril. 1996; 66: 275—80.
  8. Griesinger G., Kolibianakis E.M., Venetis C., Diedrich K., Tarlatzis B. Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil. Steril. 2010; 94(6): 238—44.
  9. Griesinger G., Venetis C.A., Marx T., Diedrich K., Tarlatzis B.C., Kolibianakis E.M. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis. Fertil. Steril. 2008; 90: 1055—63.
  10. Gonen Y., Jacobson W., Casper R.F. Gonadotropin suppression with oral contraceptives before in vitro fertilization. Fertil. Steril. 1990; 53(2): 282—7.
  11. Blockeel C., Engels S., De Vos M., Haentjens P., Polyzos N.P., Stoop D. et al. Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. Reprod. Biomed. Online. 2012; 24: 272—80.
  12. Cédrin-Durnerin I., Bständig B., Parneix I., Bied-Damon V., Avril C., Decanter C., Hugues J.N. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum. Reprod. 2007; 22(1): 109—16.
  13. Huirne J.A., van Loenen A.C., Donnez J., Pirard C., Homburg R., Schats R. et al. Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study. Reprod. Biomed. Online. 2006; 13(2): 235—45.
  14. Rombauts L., Healy D., Norman R.J., on the behalf of the Orgalutran Scheduling Study Group. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum. Reprod. 2006; 21: 95—103.
  15. Kolibianakis E.M., Papanikolaou E.G., Camus M., Tournaye H., Van Steirteghem A.C., Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum. Reprod. 2006; 21(2): 352—7.
  16. Garcia-Velasco J.A., Kupesic S., Pellicer A., Bourgain C., Simon C., Mrazek M., Devroey P. Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial. Reprod. Biomed. Online. 2012; 24: 153—62.
  17. Younis J.S., Soltsman S., Izhaki I., Radin O., Bar-Ami S., Ben-Ami M. Early and short follicular gonadotropin-releasing hormone antagonist supplementation improves the meiotic status and competence of retrieved oocytes in in vitro fertilization-embryo transfer cycles. Fertil. Steril. 2010; 94(4): 1350—5.
  18. Fanchin R., Cunha-Filho J.S., Schonauer L.M., Kadoch I.J., Cohen-Bacri P., Frydman R. Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation. Fertil. Steril. 2003; 79: 316—21.
  19. Fanchin R., Salomon L., Castelo-Branco A., Olivennes F., Frydman N., Frydman R. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum. Reprod. 2003; 18(12): 698—703.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies